{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:35Z","timestamp":1793210855087,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1053\/j.gastro.2005.06.022","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T13:39:54Z","timestamp":1126100394000},"page":"819-826","source":"Crossref","is-referenced-by-count":236,"title":["Increased Risk for Demyelinating Diseases in Patients With Inflammatory Bowel Disease"],"prefix":"10.1053","volume":"129","author":[{"given":"Gauree","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2005.06.022_bib1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.10370","article-title":"Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis","volume":"46","author":"Prahalad","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2005.06.022_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/123.6.1102","article-title":"Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey","volume":"123","author":"Broadley","year":"2000","journal-title":"Brain"},{"key":"10.1053\/j.gastro.2005.06.022_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1034\/j.1600-0404.2000.101001036.x","article-title":"Autoimmune diseases in families of French patients with multiple sclerosis","volume":"101","author":"Heinzlef","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/j.gastro.2005.06.022_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.53.4.883","article-title":"Association of MS with thyroid disorders","volume":"53","author":"Karni","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","article-title":"Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis","volume":"250","author":"Niederwieser","year":"2003","journal-title":"J Neurol"},{"key":"10.1053\/j.gastro.2005.06.022_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4049\/jimmunol.164.3.1564","article-title":"Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis","volume":"164","author":"Bergsteinsdottir","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2005.06.022_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.38.3.371","article-title":"Autoimmunity in multiple sclerosis","volume":"38","author":"De Keyser","year":"1988","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/cs0930479","article-title":"Genetic susceptibility to the development of autoimmune disease","volume":"93","author":"Heward","year":"1997","journal-title":"Clin Sci (Colch)"},{"key":"10.1053\/j.gastro.2005.06.022_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198602273140921","article-title":"Possible familial association of multiple sclerosis and inflammatory bowel disease","volume":"314","author":"Minuk","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.06.022_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM198909143211115","article-title":"Concurrence of multiple sclerosis and inflammatory bowel disease","volume":"321","author":"Sadovnick","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2005.06.022_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4065\/75.8.802","article-title":"Concurrence of inflammatory bowel disease and multiple sclerosis","volume":"75","author":"Kimura","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2005.06.022_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(82)90629-8","article-title":"Association of ulcerative colitis and multiple sclerosis","volume":"2","author":"Rang","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2005.06.022_bib13","first-page":"892","article-title":"Morbid associations in Crohn\u2019s disease. Study of a series of 832 patients","volume":"26","author":"Beaugerie","year":"1997","journal-title":"Presse Med"},{"key":"10.1053\/j.gastro.2005.06.022_bib14","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2005.06.022_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib16","unstructured":"FDA MedWatch. Detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER)\u2014May 2004. FDA\/CDER\/Office of Drug Safety 2004. Available: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/may04.htm#Enbrel. Accessed July 28, 2004."},{"key":"10.1053\/j.gastro.2005.06.022_bib17","unstructured":"FDA MedWatch. Detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER)\u2014June 2004. FDA\/CDER\/Office of Drug Safety 2004. Available: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/jun04.htm. Accessed July 28, 2004."},{"key":"10.1053\/j.gastro.2005.06.022_bib18","unstructured":"FDA MedWatch. 2004 safety alerts for drugs, biologics, medical devices, and dietary supplements. FDA\/CDER\/Office of Drug Safety 2004. Available: http:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/safety04.htm#remicade. Accessed July 28, 2004."},{"issue":"Suppl 35","key":"10.1053\/j.gastro.2005.06.022_bib19","first-page":"S134","article-title":"Demyelination and inhibition of tumor necrosis factor (TNF)","volume":"22","author":"Magnano","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/j.gastro.2005.06.022_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0895-4356(94)00137-F","article-title":"The VAMP Research multi-purpose database in the U.K","volume":"48","author":"Lis","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2005.06.022_bib21","series-title":"The general practice research database","year":"1994"},{"key":"10.1053\/j.gastro.2005.06.022_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2005.06.022_bib23","series-title":"Pharmacoepidemiology","author":"Strom","year":"2000"},{"key":"10.1053\/j.gastro.2005.06.022_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1345\/aph.1A226","article-title":"Geriatric drug therapy and healthcare utilization in the United Kingdom","volume":"36","author":"Kennerfalk","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.gastro.2005.06.022_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","article-title":"Validation of information recorded on general practitioner based computerised data resource in the United Kingdom","volume":"302","author":"Jick","year":"1991","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2005.06.022_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/pds.2630010607","article-title":"Further validation of the information recorded on a general practitioner based computerized data resource in the United Kingdom","volume":"1","author":"Jick","year":"1992","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2005.06.022_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pds.698","article-title":"Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease","volume":"11","author":"Lewis","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2005.06.022_bib28","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1053\/j.gastro.2003.09.029","article-title":"Mortality in inflammatory bowel disease","volume":"125","author":"Card","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.06.022_bib29","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.54.12.2307","article-title":"Multiple sclerosis and antecedent infections","volume":"54","author":"Marrie","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","article-title":"Recombinant hepatitis B vaccine and the risk of multiple sclerosis","volume":"63","author":"Hernan","year":"2004","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.gastro.2003.12.003","article-title":"Seasonal variation in flares of inflammatory bowel disease","volume":"126","author":"Lewis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2005.06.022_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2005.06.022_bib33","first-page":"S46","article-title":"Reliability of the General Practice Research Database to identify major medical events in chronic diseases (abstr)","volume":"10","author":"Lewis","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2005.06.022_bib34","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/j.1572-0241.2000.03361.x","article-title":"Identification of a prodromal period in Crohn\u2019s disease but not ulcerative colitis","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2005.06.022_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00001648-199309000-00013","article-title":"The latent period of multiple sclerosis","volume":"4","author":"Wolfson","year":"1993","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2005.06.022_bib36","first-page":"S230","article-title":"Measuring incidence rates using GPRD","volume":"13","author":"Lewis","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2005.06.022_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pds.902","article-title":"Agreement between GPRD smoking data","volume":"13","author":"Lewis","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2005.06.022_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2005.06.022_bib39","first-page":"56","article-title":"The epidemiology of multiple sclerosis in Devon","volume":"75","author":"Fox","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.gastro.2005.06.022_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jnnp.58.1.2","article-title":"Surveying multiple sclerosis in the United Kingdom","volume":"58","author":"Robertson","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.gastro.2005.06.022_bib41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"10.1053\/j.gastro.2005.06.022_bib42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s004150200002","article-title":"A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds","volume":"249","author":"Ford","year":"2002","journal-title":"J Neurol"},{"key":"10.1053\/j.gastro.2005.06.022_bib43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/oxfordjournals.aje.a009746","article-title":"Multiple sclerosis prevalence in the UK estimated by capture-recapture methodology","volume":"149","author":"Forbes","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2005.06.022_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/jnnp.49.10.1115","article-title":"The distribution of multiple sclerosis in the United Kingdom","volume":"49","author":"Swingler","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.gastro.2005.06.022_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jnnp.64.5.605","article-title":"The prevalence of multiple sclerosis in the Leeds Health Authority","volume":"64","author":"Ford","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.gastro.2005.06.022_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jech.50.3.274","article-title":"Multiple sclerosis in south Cambridgeshire","volume":"50","author":"Robertson","year":"1996","journal-title":"J Epidemiol Community Health"},{"key":"10.1053\/j.gastro.2005.06.022_bib47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"10.1053\/j.gastro.2005.06.022_bib48","unstructured":"Jones P. MS prevalence data for selected countries. All about multiple sclerosis. 1999. Multiple Sclerosis Information Trust. Accessed: January 15, 2005. Available: http:\/\/www.mult-sclerosis.org\/prev_tab.html."},{"key":"10.1053\/j.gastro.2005.06.022_bib49","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/01.WNL.0000094316.90240.EB","article-title":"Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985\u20132000","volume":"61","author":"Mayr","year":"2003","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2005.06.022_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"Edwards","year":"2004","journal-title":"Mult Scler"},{"key":"10.1053\/j.gastro.2005.06.022_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","article-title":"Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn\u2019s disease","volume":"10","author":"Thomas","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2005.06.022_bib52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/135245850000600512","article-title":"Long term azathioprine fails to suppress onset of multiple sclerosis","volume":"6","author":"Constantinescu","year":"2000","journal-title":"Mult Scler"},{"issue":"Suppl 6","key":"10.1053\/j.gastro.2005.06.022_bib53","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.63.12_suppl_6.S8","article-title":"Current approved options for treating patients with multiple sclerosis","volume":"63","author":"Rizvi","year":"2004","journal-title":"Neurology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505011248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508505011248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T01:01:56Z","timestamp":1553043716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508505011248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0016508505011248"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2005.06.022","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}